Combination Study with JS016 and LY-CoV555 for Patients with Mild-to-Moderate COVID-19 Symptoms Met Primary and Secondary Endpoints
Nulla a velit quis ex ornare rhoncus. Donec imperdiet risus justo, vel malesuada erat fermentum at. Morbi at laoreet mauris.…